Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Chlorthalidone Tablets USP, 25 mg and 50 mg. The Company has enclosed press release.
The above information is a part of company’s filings submitted to BSE.